MedTrace Logo

The Effect of 7 Days of Letrozole Pretreatment Combined With Misoprostol on the Placental and Decidual Tissues

NCT02457312 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-12-10

No results posted yet for this study

Summary

The present study aims at studying the effect of letrozole in early pregnancy in placenta and decidua including the progesterone receptor and the apoptotic factors.

Conditions

  • Pregnancy

Interventions

DRUG

Letrozole

letrozole 10 mg daily for 7 days before suction evacuation

DRUG

Placebo

placebo tablets which look identical to the letrozole tablets for 7 days before suction evacuation

Sponsors & Collaborators

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Vivian CY Lee, MBBS · The University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-05-31
Completion
2013-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02457312 on ClinicalTrials.gov